Next-Generation Cancer Diagnostics: Technologies and Global Markets
Report Highlights
The total global annual market for next generation cancer diagnostics was $776 million in 2010, and is growing at a compound annual growth rate (CAGR) of 47%, to reach a forecast market size of $5.3 billion in 2015.
Report Scope
The study scope includes the major next generation formats that are likely to become commercialized within the next 5 years. Each technology format is analyzed to determine its market status, impact on future market segments, and projected growth from 2010 through 2015. Technology issues and forces driving the market are discussed.
Influencing factors, including cancer diagnostics needs, regulatory trends, industry structure, and patent status are also discussed.
BCC examines companies in the industry, corporate alliances, and assay consumption by indication. We profile 108 companies participating in the industry.
Analyst Credentials
John Bergin has held business development, sales and marketing positions with a Fortune 500 advanced materials company, as well as executive management positions with a nanotechnology/separations company. Bergin holds a B.S. degree in Chemistry, an M.S. degree in Biotechnology and a Master of Business Administration. John Bergin is a pseudonym of the author.